Skip to main content Back to Top
Advertisement

Implementing Pharmacogenomics Services at Mayo Clinic

Broadcast Date: February 4, 2022

 

Subscribe on iTune PodcastsListen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

ASHP is committed to advancing the field of pharmacogenomics and educating members on patient specific pharmacogenomics testing, dosing and monitoring of medications to improve health outcomes. This podcast episode explores the important role pharmacists play in pharmacogenomics from a practice and research perspective and leading pharmacogenomics services implementation at Mayo Clinic.

SPEAKERS

Chris GrilliDr. Chris Grilli, PharmD, MBA, BCACP has held positions as a pharmacist, researcher, and administrator responsible for overseeing the ambulatory pharmacy’s practice, research, and education operation for Mayo Clinic Arizona. Dr. Grilli is a member of the Mayo Clinic Pharmacogenomics task force, Vice Chair of Mayo Clinic’s Enterprise-Wide Pharmacogenomics Subcommittee and served as assistant secretary to the Pharmacy and Therapeutics Subcommittee.

Sophia ChhaySophia R. Chhay, PharmD, is the assistant director of the ASHP Innovation Center. In this role, Sophia helps lead and manage efforts to implement new programs and partnerships for ASHP. She also provides support for strategic planning, executive communications, and operations for the Office of the COO and Senior Vice President. She serves as secretary to the Council on Education and Workforce Development and co-program coordinator for the ASHP Executive Fellowship in Association Leadership and Management.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.